Healthcare investors should enjoy the respite in the healthcare sector
over the next few weeks. Once the calendar turns to September, major
conferences start again, early earnings warnings will begin to pop up
and analysts and investors in general will start to pay a great deal
more attention to the companies and stocks. Likewise, while the FDA's calendar is relatively empty this month, activity ought to be picking up shortly.